| View |
|
DRP-14246
|
Metformin Hydrochloride
|
Etromin 850
|
850mg
|
Film-Coated Tablet
|
-
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Initial
|
02 August 2023
|
02 August 2025
|
| View |
|
DRP-14245
|
Metformin Hydrochloride
|
Etromin 1000
|
1000mg
|
Film-Coated Tablet
|
-
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Initial
|
02 August 2023
|
02 August 2025
|
| View |
|
DRHR-2271
|
Methyl Salicylate + Camphor + Menthol
|
Efficascent Oil – Extra Strength
|
22 mg / 75 mg / 60 mg per mL
|
Liniment
|
-
|
International Pharmaceuticals, Inc.
|
Philippines
|
Initial
|
03 August 2023
|
03 August 2025
|
| View |
|
DRHR-2272
|
Methyl Salicylate + Camphor + Menthol
|
Efficascent Oil
|
168.73 mg / 38.46 mg / 4.23 mg per mL
|
Liniment
|
-
|
International Pharmaceuticals, Inc.
|
Philippines
|
Initial
|
03 August 2023
|
03 August 2025
|
| View |
|
DRHR-2270
|
Menthol + Eucalyptus Oil + Camphor
|
Efficascent Relaxscent Oil
|
453.44 mg / 43.6 mg / 43.6 mg per mL
|
Liniment
|
-
|
International Pharmaceuticals, Inc.
|
Philippines
|
Initial (Correction)
|
23 January 2024
|
03 August 2025
|
| View |
|
DRP-14271
|
Terbinafine (as hydrochloride)
|
Akrifine
|
10 mg/g (1%w/w)
|
Cream
|
-
|
AKRITI PHARMACEUTICALS PVT. LTD.
|
India
|
Initial
|
07 August 2023
|
07 August 2028
|
| View |
|
HRP-625
|
Chlorhexidine (as gluconate)
|
Chlorgen
|
40 mg/mL (4% w/v)
|
Topical Solution
|
-
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Initial
|
01 August 2023
|
01 August 2028
|
| View |
|
HRP-624
|
Chlorhexidine (AS Gluconate)
|
Rapichlor
|
40 mg/mL (4% w/v)
|
Topical Solution
|
-
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Initial
|
01 August 2023
|
01 August 2028
|
| View |
|
DRP-14233
|
Ferrous Sulfate
|
Sapheron
|
500 mg
|
Capsule
|
-
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
Initial
|
01 August 2023
|
01 August 2028
|
| View |
|
DRP-14234
|
Paracetamol
|
Porfever
|
500 mg
|
Tablet
|
-
|
Rhydburg Pharmaceuticals Ltd.
|
India
|
Initial
|
01 August 2023
|
01 August 2028
|
| View |
|
DRP-14240
|
Gliclazide
|
Glycoc
|
80mg
|
Tablet
|
-
|
Fredun Pharmaceuticals Limited
|
India
|
Initial
|
02 August 2023
|
02 August 2028
|
| View |
|
DRP-14249
|
Pioglitazone (as hydrochloride)
|
Ziaton
|
30mg
|
Tablet
|
-
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Initial
|
02 August 2023
|
02 August 2028
|
| View |
|
DRHR-2274
|
Isopropyl Alcohol
|
None
|
70% (v/v) Topical Solution
|
Topical Solution
|
-
|
Ceres Summit Corporation
|
Philippines
|
Initial
|
07 August 2023
|
07 August 2028
|
| View |
|
DRP-14232
|
Paracetamol + Chlorpheniramine Maleate + Phenylephrine Hcl + Caffeine
|
Hirafen
|
500 mg/5 mg/2 mg/30 mg
|
Tablet
|
-
|
HIRAL LABS LIMITED
|
India
|
Initial
|
01 August 2023
|
01 August 2028
|
| View |
|
DRP-14261
|
Levothyroxine Sodium (as hydrate)
|
Thyrofix
|
25 mcg
|
Tablet
|
-
|
Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories
SA
|
Greece
|
Initial
|
04 August 2023
|
04 August 2028
|
| View |
|
DRP-14265
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Azilin
|
4g/500 mg
|
Powder for Injection (IV)
|
-
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
Initial
|
07 August 2023
|
07 August 2028
|
| View |
|
DRP-14250
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Tazofour
|
4g/500 mg
|
Powder for Injection (IV)
|
-
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
Initial (Correction)
|
29 September 2023
|
03 August 2028
|
| View |
|
DRP-14239
|
Pantoprazole (as sodium sesquihydrate)
|
Pantomacid
|
40 mg
|
Lyophilized Powder For Injection
|
-
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
Initial
|
02 August 2023
|
02 August 2028
|
| View |
|
DRP-14252
|
Pantoprazole (As Sodium)
|
Novazol-20
|
20mg
|
Enteric-Coated Tablet
|
-
|
Ratnamani Healthcare Pvt. Ltd.
|
India
|
Initial (Re-application)
|
03 August 2023
|
03 August 2028
|
| View |
DR-XY48818_PI_01.pdf
|
DR-XY48818
|
Levonorgestrel
|
Jadelle
|
75mg
|
Implant (For Subdermal Use Only)
|
-
|
Bayer Oy
|
Finland
|
Monitored Release (MR) (Re-application)
|
31 July 2023
|
21 July 2028
|